Sex-specific considerations in nanomedicine : highlighting the impact of the menstrual cycle on drug development
Tweetable abstract The female menstrual cycle is one of the most overlooked sex-specific factors in drug distribution and response. Unlocking the potential of nanomedicine demands a fundamental understanding of the impact biological sex has on drug distribution, efficacy and adverse effects.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:19 |
|---|---|
| Enthalten in: |
Nanomedicine (London, England) - 19(2024), 7 vom: 21. März, Seite 557-560 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Poley, Maria [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Clinical trials |
|---|
| Anmerkungen: |
Date Completed 12.03.2024 Date Revised 20.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.2217/nnm-2023-0347 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM366181858 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM366181858 | ||
| 003 | DE-627 | ||
| 005 | 20240420232213.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231227s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2217/nnm-2023-0347 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1381.xml |
| 035 | |a (DE-627)NLM366181858 | ||
| 035 | |a (NLM)38127525 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Poley, Maria |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Sex-specific considerations in nanomedicine |b highlighting the impact of the menstrual cycle on drug development |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 12.03.2024 | ||
| 500 | |a Date Revised 20.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Tweetable abstract The female menstrual cycle is one of the most overlooked sex-specific factors in drug distribution and response. Unlocking the potential of nanomedicine demands a fundamental understanding of the impact biological sex has on drug distribution, efficacy and adverse effects | ||
| 650 | 4 | |a Editorial | |
| 650 | 4 | |a clinical trials | |
| 650 | 4 | |a drug development | |
| 650 | 4 | |a hormonal changes | |
| 650 | 4 | |a menstrual cycle | |
| 650 | 4 | |a nanomedicine | |
| 650 | 4 | |a nanoparticles | |
| 650 | 4 | |a protein corona | |
| 650 | 4 | |a sex differences | |
| 650 | 4 | |a sex-specific analysis | |
| 650 | 4 | |a women's health | |
| 773 | 0 | 8 | |i Enthalten in |t Nanomedicine (London, England) |d 2006 |g 19(2024), 7 vom: 21. März, Seite 557-560 |w (DE-627)NLM17228452X |x 1748-6963 |7 nnns |
| 773 | 1 | 8 | |g volume:19 |g year:2024 |g number:7 |g day:21 |g month:03 |g pages:557-560 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2217/nnm-2023-0347 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 19 |j 2024 |e 7 |b 21 |c 03 |h 557-560 | ||